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Objective To estimate recurrence risk of gestational diabetes
mellitus (GDM) by interpregnancy weight change.
Design Population-based cohort study.
Setting and population Data from the Swedish (1992–2010) and
the Norwegian (2006–2014) Medical Birth Registries on 2763
women with GDM in first pregnancy, registered with their first
two singleton births and available information on height and
weight.
Methods Interpregnancy weight change (BMI in second pregnancy
minus BMI in first pregnancy) was categorised in six groups by
BMI units. Relative risks (RRs) of GDM recurrence were obtained
by general linear models for the binary family and adjusted for
confounders. Analyses were stratified by BMI in first pregnancy
(<25 and ≥25 kg/m2).
Main outcome measure GDM in second pregnancy.
Results Among overweight/obese women (BMI ≥25), recurrence
risk of GDM decreased in women who reduced their BMI by 1–2
units (relative risk [RR] 0.80, 95% CI 0.65–0.99) and >2 units
(RR 0.72, 95% CI 0.59–0.89) and increased if BMI increased by
≥4 units (RR 1.26, 95% CI 1.05–1.51) compared wth women with
stable BMI (1 to 1 units). In normal weight women (BMI <25),
risk of GDM recurrence increased if BMI increased by 2–4 units
(RR 1.32, 95% CI 1.08–1.60) and ≥4 units (RR 1.61, 95% CI
1.28–2.02) compared with women with stable BMI.
Conclusion Interpregnancy weight loss reduced risk of GDM
recurrence in overweight/obese women. Weight gain between
pregnancies increased recurrence risk for GDM in both normal
and overweight/obese women. Our findings highlight the
importance of weight management in the interconception window
in women with a history of GDM.
Keywords Body mass index, gestational diabetes, interpregnancy,
recurrence, weight change.
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Introduction
Gestational diabetes mellitus (GDM) is defined as glucose
intolerance of various degrees that is detected during
pregnancy.1 Women with GDM have increased risks of
metabolic syndrome,2 type 2 diabetes mellitus3 and car-
diovascular disease later in life.4 Children born to women
with GDM have an increased risk of high birthweight and
long-term metabolic disease, indicating transmission of
risk through generations due to genetic, epigenetic and
environmental influence.5 The incidence of GDM in Eur-
ope varies by country and population but has increased
over the last decades,6 contributing to a considerable
increase in national medical costs.7 The recurrence risk of
GDM is high,8 and an American population-based study
found that close to 50% of women with GDM in their
first pregnancy also developed GDM in their second
pregnancy.9
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Numerous risk factors for GDM have been identified,
including maternal age, prepregnancy body mass index
(BMI), nonwhite ethnicity, family history of diabetes melli-
tus, weight gain in early adulthood and cigarette smoking;
however, findings are inconsistent and vary across stud-
ies.8,10 Weight change between pregnancies may be an
independent risk factor for GDM in women without GDM
in first pregnancy,11,12 and weight loss in women who were
overweight at start of first pregnancy has been associated
with reduced risk of GDM in second pregnancy,12,13
although not consistently in all studies.11,14 The high preva-
lence of overweight15 and the increasing trend of GDM in
reproductive women across the world emphasise the neces-
sity to focus on weight change as a modifiable risk factor
for GDM.
Understanding of underlying mechanisms of GDM is
scarce and limits the ability for targeted interventions. As
maternal weight is amenable to intervention, evidence of a
preventive effect of weight loss on GDM recurrence will be
crucial in public health strategies promoting healthy weight
in the entire reproductive window. We pursued this by
using population-based family data from two Scandinavian
countries.
The specific aims were to estimate the association
between weight change from first to second pregnancy and
recurrence risk for GDM, and to explore the modifying
role of BMI in first pregnancy.
Methods
Study design
This population-based cohort study has analysed har-
monised and pooled data from the Swedish (1992–2010)
and Norwegian (2006–2014) Medical Birth Registries. The
study periods were based on available information on
maternal height and weight in the two registries and an
established research collaboration between Sweden and
Norway. The unique national identification numbers
assigned to each citizen residing in these countries, enabled
linkage of all births to each woman. Mothers with their
first two successive singleton births during the study peri-
ods constituted the study unit in the analyses. Both
national birth registries have collected data prospec-
tively16,17 and are based on compulsory notification of all
live- and stillbirths. Antenatal, obstetric and early neonatal
care data are by law collected by standardised notification
forms, and include demographic characteristics, reproduc-
tive history, maternal health before and during pregnancy,
pregnancy and delivery complications, and outcomes.18,19
In the Swedish data, maternal height and weight mea-
sured in light clothing at the first antenatal visit were regis-
tered from 1992. Roughly 90% of Swedish women had
their first antenatal visit before 12 completed weeks.16 In
Norway, self-reported height and prepregnancy weight
from the antenatal charts were included when electronic
notification of births was implemented in the birth registry.
The implementation was gradual and initiated at different
years for the more than 50 delivery units in the country
(from 2006 to 2014) and was not linked to a specific type
of delivery unit or specific group of delivering women.17
Smoking habits at the beginning of pregnancy have been
registered in Sweden since 1983 and in Norway since 1999.
Educational level represents the highest achieved level of
education obtained from the Education Registry in Sweden
and from the National Education Database at Statistics
Norway. Information on mother’s country of birth was
obtained from the Swedish Immigration Registry and
Statistics Norway.
Population
We included women with singleton births in first and sec-
ond pregnancy, without diabetes mellitus prior to first
pregnancy. Women who had developed diabetes mellitus
type 1 or 2 by the time of their second pregnancy were
excluded. To evaluate the association between weight
change and recurrence of GDM, we focused on women
with GDM in first pregnancy whose BMI was reported in
both pregnancies. There was no patient or public involve-
ment in the development of this research.
Exposure and outcome
Maternal weight was registered in kilograms (kg) and
maternal height in meters (m) with three digits in both
birth registries. In cases with missing height in one preg-
nancy, height in the other pregnancy was used. If height
differed by less than 2 or +2 cm we used the registered
height in first pregnancy. If height differed by more than
2 or +2 cm, z-scores for height (observed height  popu-
lation mean height/population standard deviation) was cal-
culated based on the population of women with GDM in
first pregnancy who had no difference in registered height
in first and second pregnancy. Women with z-scores for
height >4 or <4 in first or second pregnancy were
excluded, as data were considered implausible. BMI in first
and second pregnancy was calculated from weight in kg
divided by height in m2 and categorised as underweight
(<18.5), normal weight (18.5–24.9), overweight (25.0–29.9),
obese class I (30–34.9) and obese class II/III (≥35).20 In
stratified analyses, BMI in first pregnancy was dichotomised
into <25 and ≥25.20 Interpregnancy interval was calculated
as date of second birth minus date of first birth minus ges-
tational age of second pregnancy and was categorised into
<12, 12–23, 24–35 and ≥36 months. To have an equal dis-
tribution of women within strata, year of second birth was
categorised according to 30 percentiles (1992–2001, 2002–
2006, 2007–2014).
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The main exposure was interpregnancy weight change,
defined as BMI in second pregnancy minus BMI in first
pregnancy, expressed as units BMI (kg/m2) (one BMI unit
is equivalent to approximately a 2.7-kg reduction or
increase in weight in a woman who is 1.68 m tall and
weighs 65 kg). Interpregnancy weight change was cate-
gorised as: <2, 2 to <1, 1 to <1 (stable BMI, used as
reference), 1 to <2, 2 to <4 and ≥4 kg/m2.12,21
The main outcome was GDM (yes/no), notified via a
check box on the birth notification form or as diagnostic
codes according to the International Classification of Dis-
eases (ICD) Swedish version 9 (648W) and ICD-10 (O244).
The diagnostic criteria of GDM during the entire study
period in Norway were: fasting plasma glucose levels <7.0
mmol/l and serum blood glucose following an oral glucose
tolerance test (2 hours after intake of 75 g oral glucose) of
≥7.8 mmol/l but <11.1 mmol/l, defined according to the
National Guidelines by the Norwegian Society of Gynaecol-
ogy and Obstetrics.22 For Sweden, the main diagnostic cri-
terion for the disease was based on a 75-g oral glucose
tolerance test with a fasting capillary blood glucose level
≥6.1 mmol/l and/or a 2-hour capillary blood glucose
≥9.0 mmol/l.23,24 In Norway and most parts of Sweden,
selective glucose tolerance tests are performed based on
known risk factors.22–24 However, practices concerning
screening and diagnostic criteria of GDM in Sweden vary
in the different healthcare settings.23,24
Statistical analysis
Chi-square tests were used to indicate associations and lin-
ear trends. Generalised linear models with log link, bino-
mial distribution and exponentiated regression coefficients
were used to calculate relative risks (RR) with 95% confi-
dence intervals (CI) for the association between recurrent
GDM and interpregnancy weight change categories. The
reference category was stable weight (1 to <1 BMI units).
We used the theoretical framework directed acyclic graphs
(DAG) with ‘dagitty’ version 2.3 (www.dagitty.net) to visu-
alise possible causal pathways25 (Figure S1). Maternal age
at second delivery (<25, 25–29, ≥30 years), year of second
birth (1992–2001, 2002–2006, 2007–2014), education in
years (<10, ≥10), maternal country of birth (Nordic [Nor-
way, Sweden, Denmark, Finland and Iceland], non-Nordic,
missing), smoking at the start of second pregnancy (yes,
no, missing) and interpregnancy interval (<24, ≥24
months), were considered possible confounders and
adjusted for in the multivariable model.8,10,26 We handled
missing data on covariates (3.9%, 108/2763) by including
simple imputation methods and assigning a separate value
for missing data in the adjusted model. We also performed
missing imputation using chained equations (MICE)27 with
logistic regression for smoking, maternal country of birth
and maternal education; however, adjusted models were
almost unchanged. A potential effect modification by BMI
in first pregnancy (BMI <25 and BMI ≥25) was evaluated
by including an interaction term (BMI in first preg-
nancy 9 BMI change between pregnancies) in the multi-
plicative model (assessed by likelihood-ratio test). Analyses
were stratified by BMI in first pregnancy, interpregnancy
interval, maternal education, smoking at the start of second
pregnancy, year of second birth and maternal country of
birth.
Finally, as a sensitivity analysis, we evaluated whether
interpregnancy weight change trajectories influenced GDM
recurrence risk additionally to that of the absolute BMI in
second pregnancy (Table S1). By combining BMI categories
(BMI <25, 25.0–29.9 and ≥30 kg/m2)20 in first and second
pregnancy, we were able to calculate absolute risks of GDM
recurrence with 95% CI for each of the nine interpregnancy
weight change trajectories.
Associations were considered statistically significant at
the 5% level. The statistical analyses were performed using
STATA IC Statistical software version 15 and IBM SPSS
statistical software version 25 (www.spss.com).
Results
Inclusions and exclusions are shown in Figure 1. In the
two registries, 614 432 women had singleton first and sec-
ond births without established diabetes mellitus. Among
these, 4078 women were registered with GDM in their first
pregnancy (2957 in Sweden and 1121 in Norway). After
excluding 1315 (32.2%) women with missing information
on BMI, a total of 2763 women (2414 Swedish and 349
Norwegian women) were left for analyses of GDM recur-
rence risk. The population with available information on
BMI in both pregnancies (n = 2763) was compared with
the population with missing information on BMI
(n = 1315) with respect to maternal characteristics and risk
of GDM recurrence (Table S2). There was a higher propor-
tion of missing data and a higher absolute risk of GDM
recurrence (571/1315, 43.4%) in the population with miss-
ing information on BMI.
The overall recurrence risk for GDM in second preg-
nancy was 39% (Table 2). BMI in first pregnancy and
maternal age in second pregnancy were associated with
GDM recurrence (Table 1). For women with BMI <25 and
≥25 in first pregnancy, the recurrence rates were 33.6%
(425/1264) and 43.6% (653/1499), respectively (Tables S3
and S4).
In women with GDM in first pregnancy, 19.7% had a
weight loss >1 BMI unit, 39.8% were stable in weight and
40.5% increased their weight by ≥1 BMI unit (Table 2).
Among women with weight loss of >2 BMI units between
first and second pregnancy, 85% (n = 225) were overweight
(BMI ≥ 25) and 15% (n = 39) were normal weight at the
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start of first pregnancy. Compared with women who were
stable in weight between pregnancies, women with weight
loss >2 BMI units had a 20% lower risk of GDM recur-
rence (adjusted RR [aRR] 0.80, 95% CI 0.66–0.97)
(Table 2, Figure S2). GDM recurrence increased linearly
across categories of BMI change between first and second
pregnancy (P-value for trend; <0.0001) (Figure S2).
Women gaining ≥4 BMI units had a 42% increased risk of
GDM recurrence (aRR 1.42, 95% CI 1.22–1.65) compared
with women with a stable weight. Stratified analyses
revealed similar trends between BMI change and risk of
GDM recurrence in women with BMI <25 and ≥25 in first
pregnancy (Figure 2, Tables S3 and S4). There was no
interaction between BMI in first pregnancy (<25 and
≥25 kg/m2) and interpregnancy weight change categories
(v2 = 3.78, P = 0.582, likelihood-ratio test). Crude and
adjusted regression models were almost identical.
Overweight women (BMI ≥25) who reduced their weight
between pregnancies by >2 or 1–2 BMI units, had a 28%
(aRR 0.72, 95% CI 0.59–0.89) and 20% (aRR 0.80, 95% CI
0.65–0.99) lower risk of GDM recurrence respectively, com-
pared with overweight women with stable weight (Figure 2,
Table S4). In women with BMI <25 in first pregnancy,
reduced weight was not associated with a significantly
reduced risk of GDM recurrence (Figure 2, Table S3).
Women who gained ≥4 BMI units from first to second
pregnancy had an increased risk of GDM recurrence,
independent of BMI in first pregnancy (<25 and ≥25). The
crude and adjusted models differed only slightly. The asso-
ciation between interpregnancy weight change and GDM
recurrence in second pregnancy remained in stratified anal-
yses of maternal age, country of birth, year of second birth,
interpregnancy interval, smoking at the start of second
pregnancy and education (data not shown).
In sensitivity analyses, investigating absolute GDM recur-
rence risk by categories of BMI in first and second preg-
nancy (Table S1) we found that for women whose BMI at
second pregnancy was 25.0–29.9 (overweight), the lowest
risk of GDM recurrence in second pregnancy (26.8%, 95%
CI 16.7–39.1) was found for women who reached this BMI
category by losing weight (from BMI ≥30 in first preg-
nancy), whereas the highest risk (44.7%, 95% CI 38.4–51.1)
was found for women who gained weight (from BMI <25
in first pregnancy). Similar trends were found both for




Overweight/obese women (BMI ≥25) with weight loss >2
or 1–2 BMI units between pregnancies, had a 28% (aRR
0.72, 95% CI 0.59–0.89) and 20% (aRR 0.80, 95% CI 0.65–
0.99) lower risk of GDM recurrence, respectively, compared
Figure 1. Flow chart showing inclusion and exclusion in our study.
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with overweight women with stable weight. Gaining weight
between pregnancies was associated with increased risk of
GDM recurrence in women with a BMI <25 as well as ≥25
in first pregnancy.
Strengths and limitations
The family design enabled us to study how weight change
from first to second pregnancy revealed a heterogeneity in
risk of GDM recurrence, which underlines that GDM
recurrence is not only determined by genetic factors but
seems amenable to intervention. A large sample size
enabled us to show a dose–response association between
weight change from first to second pregnancy and risk of
recurrent GDM. The relation remained consistent across
strata, suggesting weight to be part of a metabolic mecha-
nism behind GDM. Despite strengths, there are some lim-
itations of our study. Self-reported height and weight may
have introduced misclassification bias; however, in women
Table 1. Maternal characteristics of women with gestational diabetes mellitus (GDM) in first pregnancy* according to recurrence of GDM
(n = 2763); Pooled data from the Swedish (1992–2010) and the Norwegian (2006–2014) Medical Birth Registries
GDM recurrence Total Absolute risk (%) Chi-square
No % Yes % P-value
BMI 1st pregnancy (kg/m2)
<18.5 39 2.3 19 1.8 58 32.8 <0.0005**
18.5–24.9 800 47.5 406 37.7 1206 33.7
25–29.9 458 27.2 323 30.0 781 41.4
≥30 388 23.0 330 30.6 718 46.0
Maternal age 2nd pregnancy (years)
<25 173 10.3 60 5.6 233 25.8 <0.0005**
25–29 487 28.9 294 27.3 781 37.6
≥30 1025 60.8 724 67.2 1749 41.4
Smoking at the start of 2nd pregnancy
No 1497 88.8 969 89.9 2466 39.3 0.18
Yes (daily/sometimes) 155 9.2 81 7.5 236 34.3
Missing 33 2.0 28 2.6 61 45.9
Maternal country of birth
Nordic 1227 72.8 743 68.9 1970 37.7 0.08
Non-Nordic 451 26.8 331 30.7 782 42.3
Missing 7 0.4 4 0.4 11 36.4
Maternal education (years)
<10 193 11.5 121 11.2 314 38.5 0.95
10–14 964 57.2 623 57.8 1587 39.3
>14 505 29.9 319 29.6 824 38.7
Missing 23 1.4 15 1.4 38 39.5
Marital status
Married/cohabiting 1614 96.9 1045 97.5 2659 39.3 0.36
Other 52 3.1 27 2.5 79 34.2
Missing 19 6 25
Interpregnancy interval (months)
<12 373 22.1 215 19.9 588 36.6 0.54
12–23 641 38.0 416 38.6 1057 39.4
24–35 321 19.1 220 20.4 541 40.7
≥36 350 20.8 227 21.1 577 39.3
Mother’s height (cm)
<160 354 21.0 237 22.0 591 40.1 0.47
160–164 506 30.0 297 27.6 803 37.0
165–169 458 27.2 291 27.0 749 38.9
≥170 367 21.8 253 23.5 620 40.8
Total 1685 100 1078 100 2763 39.0
*Women with singleton pregnancies without diabetes mellitus prior to first pregnancy.
**P-value for chi-square trend.
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of reproductive age, self-reported height and weight differs
only slightly from direct measures and has been found to
give valid estimates in research and for clinical use.28 Data
on height and weight were collected before the outcome
GDM, and possible misclassification of BMI would there-
fore be independent of the outcome and non-differen-
tial.29 Selection bias due to missing data on BMI is a
possibility, however, as the absolute risk of GDM recur-
rence in our study population was lower than in the pop-
ulation with missing BMI information (39.0 versus
43.6%); this will likely bias risk estimates towards the null
and underestimate the true association between weight
change and GDM recurrence. The high proportion of
missing data in the Norwegian data is suggested to be
randomly missing across the population,17 and if lack of
information is randomly assigned, impact on risk esti-
mates would be minor.16,29 In both Norway and Sweden,
a risk-based screening strategy for GDM is used. This
may result in under-reporting of GDM. Thus, our results
may not be generalisable to potentially more heteroge-
neous populations where universal screening for GDM is
established.
Figure 2. Adjusted relative risk (aRR) for recurrence of gestational diabetes mellitus (GDM) in women with body mass index (BMI) <25 (n = 1264)
and ≥25 (n = 1499) in first pregnancy; Pooled data from the Swedish (1992–2010) and the Norwegian Medical Birth Registry (2006–2014). Analyses
are adjusted for maternal age (<25 [reference], 25–29, ≥30), year of second birth (1992–2001 [reference], 2002–2006, 2007–2014), maternal
education (<10 years, ≥10 years [reference]), interpregnancy interval (<24 months, ≥24 months [reference]), maternal country of birth (Nordic
[reference], non-Nordic, missing), maternal smoking at the start of second pregnancy (no [reference], yes, missing).
Table 2. Overall relative risk (RR) for recurrence of gestational diabetes mellitus (GDM) in second pregnancy; Pooled data from the Swedish
Medical Birth Registry (1992–2010) and the Norwegian Medical Birth Registry (2006–2014) (n = 2763)
BMI change from 1st to
2nd pregnancy
1st pregnancy 2nd pregnancy Risk for GDM recurrence in 2nd pregnancy
Units, kg/m2 N (%) Mean BMI Mean BMI n/N GDM (%) Crude RR 95% CI Adj RR* 95% CI
<2 264 (9.6) 31.6 27.6 82/264 31.1 0.81 0.67–0.99 0.80 0.66–0.97
2 to <1 279 (10.1) 27.4 26.0 93/279 33.3 0.87 0.73–1.04 0.86 0.71–1.03
1 to <1 1100 (39.8) 25.9 25.9 421/1100 38.3 1.00 Reference 1.00 Reference
1 to <2 463 (16.8) 25.9 27.3 180/463 38.9 1.02 0.89–1.16 1.02 0.89–1.17
2 til <4 471 (17.0) 26.5 29.3 202/471 42.9 1.12 0.99–1.27 1.15 1.02–1.31
≥4 186 (6.7) 28.5 34.4 100/186 53.8 1.40 1.21–1.64 1.42 1.22–1.65
Total 2763 (100) 26.9 27.5 1078/2763 39.0
*Analyses adjusted for maternal age (<25 [reference], 25–29, ≥30), year of second birth (1992–2001 [reference], 2002–2006, 2007–2014),
maternal education (<10 years, ≥10 years [reference]), interpregnancy interval (<24 months, ≥24 months [reference]), maternal country of birth
(Nordic [reference], non-Nordic, missing) and maternal smoking at the start of second pregnancy (no [reference], yes, missing).
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We could not distinguish between weight change in the
interpregnancy interval and gestational weight gain during
first pregnancy, and reported weight change could be a
product of both. Unmeasured confounding by diet, exercise
and lifestyle changes cannot be excluded.
No core outcome set was used in this study.
Interpretation
Our results demonstrate that interpregnancy weight change
may alter GDM recurrence trajectory in a population of
women characterised by high GDM recurrence. The dose–
response association between interpregnancy weight change
and GDM recurrence indicates that maternal weight is a
likely causal factor behind GDM. These findings comple-
ment studies which have found that interpregnancy weight
change modified risk of GDM in a second pregnancy in a
population of women who did not have GDM in their first
pregnancy.11,12 Studies have investigated interpregnancy
weight change and risk of GDM in a second pregnancy;
however, authors have typically included women both with
and without GDM in first pregnancy13,30 or excluded
women with GDM in first pregnancy.11,12 Difference in
design and methodology make interpretation of these
results difficult.
The gestational diabetes mellitus recurrence rate in our
study is consistent with American cohort studies of similar
design, revealing a 41%31 and 38%13 GDM recurrence rate.
The high GDM recurrence rate may be due to underlying
impairment following GDM from first pregnancy, suggest-
ing that the impaired b-cell function continues even after
the stresses of pregnancy have ended.32 Defects in maternal
insulin sensitivity and secretion, may be unmasked in
response to metabolic stressors of a subsequent preg-
nancy.33 However, results from our study suggest the possi-
bility of altering the natural GDM recurrence trajectory by
changing women’s weight from first to second pregnancy.
Weight loss in overweight/obese individuals improves adi-
posity-induced systemic inflammation,34 and interpreg-
nancy weight loss in overweight women may improve
insulin sensitivity and b-cell function, resulting in a better
ability to cope with the physiological demands1,35,36 of
decreased insulin sensitivity in the subsequent pregnancy.
In contrast, weight gain is likely to increase the pressure on
the glucose metabolism, causing a sub-clinically decreased
insulin sensitivity, which may limit the metabolic capacity
in both normal weight and overweight women. This may
explain the increased risk of GDM recurrence associated
with interpregnancy weight gain found in women with
BMI <25 and women with BMI ≥25 in our study. Gener-
ally, GDM is likely to represent detection of a chronic con-
dition of low and falling b-cell compensation for chronic
insulin resistance, rather than development of an acute
condition of pregnancy.37 This hypothesis is further
strengthened by the strong association between GDM and
later type 2 diabetes mellitus.3
Results from our sensitivity analysis indicate that the
interpregnancy weight change trajectories (weight loss or
weight gain) add to the risk associated with the absolute
BMI at second pregnancy, which is most evident for
women overweight at second pregnancy. Although confi-
dence intervals were wide and overlapping, our results are
likely to have clinical importance.
Despite the well-known high risk of GDM recurrence,
care for women in the interconception period is lacking.38
The majority of women in our study (40.5%) had an inter-
pregnancy weight gain, underlining the tendency for
women to gain rather than reduce weight between preg-
nancies.39 Only 19.7% of women had an interpregnancy
weight loss >1 BMI unit. These results are comparable to
the 41.1% weight gain and 13.1% weight loss in a Swedish
study of similar design.21 Among women with an inter-
pregnancy weight loss of >2 BMI units, 85% (n = 225) had
a BMI ≥25 at the start of first pregnancy. This is evidence
that overweight/obese women who experience GDM in
their first pregnancy, may make an effort to reduce their
weight by the second pregnancy. A potential benefit of
interpregnancy weight loss on GDM recurrence should not,
however, come at the expense of increased risk of adverse
outcomes in a subsequent pregnancy. A similar study from
the UK found that women with a weight loss >1 BMI unit
had an increased risk of small for gestational age (SGA) in
second pregnancy, independent of BMI in first pregnancy.40
However, in a cohort study from Australia, they revealed
an increased risk of SGA only among normal weight
women with an interpregnancy weight loss.30 Among
women with a BMI ≥25 in first pregnancy, an interpreg-
nancy weight loss ≥2 BMI units was even associated with a
reduced risk of SGA.30
Conclusion
Overweight/obese women with a weight loss >1 BMI unit
from first to second pregnancy had a 20–28% lower risk
of GDM recurrence, compared with overweight/obese
women who were stable in weight. Gaining weight
between pregnancies was associated with increased risk of
GDM recurrence in women who had BMI < 25 and
women with BMI ≥ 25 in first pregnancy. Our results
may have implications for both healthcare and public
health strategies, aiming at promoting healthy weight in
the interconception window in women with a history of
GDM. If interpregnancy weight change is able to alter
GDM recurrence trajectory, future research should explore
whether interpregnancy weight change may modify the
strong association between GDM and later type 2 diabetes
mellitus.
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